title: [Symptomatic treatment of terminal painful glaucoma by the retrobulbar administration of aminazine].
abstract: Retrobulbar injection of 1.0-2.5% aminazin solution in terminal painful glaucoma helps avoid enucleation in 83.8% of cases. The analgesic effect of retrobulbar aminazin does not always accurately correlate with its hypotensive action on the intraocular pressure. The mechanism of the drug action is explained by a local (on the ciliary node) manifestation of aminazin neurotropism depressing the eye sensitivity to pain.
authors.forename: N I
authors.initials: NI
authors.lastname: Bastrikov
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001510:Bed Rest; D002746:Chlorpromazine / Q000008:administration & dosage*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005123:Eye; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007267:Injections / Q000379:methods; D008297:Male; D008875:Middle Aged; D011343:Procaine / Q000008:administration & dosage; D013997:Time Factors
chemical_list: D011343:Procaine; D002746:Chlorpromazine
vernacular_title: Simptomaticheskoe lechenie terminal'noĭ boliashcheĭ glaukomy retrobul'barnym vvedeniem aminazina.